Design of immunogenic and effective multi-epitope DNA vaccines for melanoma.

Design of immunogenic and effective multi-epitope DNA vaccines for melanoma.
复制标题

DOI:
10.1007/s00262-011-1110-7
复制
发表时间:
2012-03
影响因子:
5.8
通讯作者:
Celis, Esteban
Celis, Esteban
中科院分区:
医学3区
文献类型:
--
作者:
Cho, Hyun-Il;Celis, Esteban

文献摘要

参考文献

被引文献

相似文献

质粒DNA疫苗接种是一种有吸引力的方式来引发针对感染因子和肿瘤细胞的T细胞应答。DNA构建体可以被设计为含有多个T细胞表位以产生多样化的免疫应答,从而将许多抗原并入并减少由于MHC限制而导致的限制性进入单个实体。我们已经制备了cDNA质粒构建体,其中含有几个小鼠T细胞表位连接的弗林蛋白酶敏感或抗性接头,并研究了阳离子细胞穿透序列从HIV-tat的影响。用多表位DNA疫苗,然后进行体内电穿孔,获得显著的CD 8 T细胞应答,而不管所用接头的类型和构建体是否具有HIV-tat序列。免疫应答的幅度与每个疫苗构建体中包含的所有CD 8 T细胞表位非常相似,表明不存在免疫显性。将辅助性T细胞表位插入构建体中增加了T细胞应答。使用含有来自黑素体蛋白的表位的构建体获得了针对B16黑色素瘤的预防性和治疗性抗肿瘤应答,表明这种疫苗接种成功地产生了对自身抗原的应答,所述自身抗原可能受到免疫耐受。这些发现对于设计用于多种疾病的DNA疫苗是有用的,其中T淋巴细胞发挥保护或治疗作用。
Plasmid DNA vaccination is an attractive way to elicit T cell responses against infectious agents and tumor cells. DNA constructs can be designed to contain multiple T cell epitopes to generate a diverse immune response to incorporate numerous antigens and to reduce limitations due to MHC restriction into a single entity. We have prepared cDNA plasmid constructs containing several mouse T cell epitopes connected by either furin-sensitive or resistant linkers, and studied the effects of a cationic cell penetrating sequence from HIV-tat. Significant CD8 T cell responses were obtained with multi-epitope DNA vaccines followed by in vivo electroporation regardless of the type of linker used and whether the construct had the HIV-tat sequence. The magnitude of immune responses was very similar to all CD8 T cell epitopes contained within each vaccine construct indicating the absence of immunodominance. Incorporating a T helper epitope into the constructs increased the T cell responses. Prophylactic and therapeutic anti-tumor responses against B16 melanoma were obtained using a construct containing epitopes from melanosomal proteins, indicating that this vaccination was successful in generating responses to self-antigens that potentially may be subjected to immune tolerance. These findings are useful for designing DNA vaccines for a multitude of diseases where T lymphocytes play a protective or therapeutic role.
DOI: 10.1158/0008-5472.can-06-3290
发表时间: 2007-02-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Nava-Parada, Pilar;Forni, Guido;Celis, Esteban
通讯作者: Celis, Esteban
DOI: 10.1038/ni.1728
发表时间: 2009-06-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Tenzer, Stefan;Wee, Edmund;Iversen, Astrid K. N.
通讯作者: Iversen, Astrid K. N.
DOI: 10.4049/jimmunol.166.12.7063
发表时间: 2001-06-15
影响因子: 4.4
作者:
Lu, J;Wettstein, PJ;Celis, E
通讯作者: Celis, E
DOI: 10.1016/s0264-410x(98)00238-2
发表时间: 1999-02-12
期刊: VACCINE
影响因子: 5.5
作者:
Hanke, T;Neumann, VC;McMichael, A
通讯作者: McMichael, A
DOI: 10.1158/0008-5472.can-08-3134
发表时间: 2008-12-01
期刊: Cancer research
影响因子: 11.2
作者:
Assudani D;Cho HI;DeVito N;Bradley N;Celis E
通讯作者: Celis E